Valvular heart disease and the use of cabergoline for the treatment of prolactinoma

Neil Herring, Cezary Szmigielski, Harald Becher, Niki Karavitaki, John A. H. Wass
  • Clinical Endocrinology, January 2009, Wiley
  • DOI: 10.1111/j.1365-2265.2008.03458.x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/j.1365-2265.2008.03458.x

The following have contributed to this page: Dr Niki Karavitaki